124 related articles for article (PubMed ID: 32252927)
1. Rebuttal From Dr Frantz.
Frantz RP
Chest; 2020 Apr; 157(4):768-769. PubMed ID: 32252927
[No Abstract] [Full Text] [Related]
2. Selexipag Use in Clinical Practice: Mind the Gap.
White RJ; Lachant DJ
Chest; 2020 Apr; 157(4):761-763. PubMed ID: 32252924
[No Abstract] [Full Text] [Related]
3. Add-on parenteral therapy in pulmonary arterial hypertension: The good, the bad, and the ugly.
Schoenberg NC; Farber HW
J Heart Lung Transplant; 2019 Sep; 38(9):1003-1005. PubMed ID: 31495406
[No Abstract] [Full Text] [Related]
4. Rebuttal From Drs Channick and Saggar.
Channick RN; Saggar R
Chest; 2019 Dec; 156(6):1047-1048. PubMed ID: 31812191
[No Abstract] [Full Text] [Related]
5. Rebuttal From Drs Humbert and Lau.
Humbert M; Lau EMT
Chest; 2019 Dec; 156(6):1045-1046. PubMed ID: 31812190
[No Abstract] [Full Text] [Related]
6. An Event-driven Trial for Oral Treprostinil. Progress but Not the Holy Grail.
Hill NS; Farber HW; Preston IR
Am J Respir Crit Care Med; 2020 Mar; 201(6):647-649. PubMed ID: 31904994
[No Abstract] [Full Text] [Related]
7. Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension.
Tokunaga N; Ogawa A; Ito H; Matsubara H
J Cardiol; 2016 Dec; 68(6):542-547. PubMed ID: 27005767
[TBL] [Abstract][Full Text] [Related]
8. Epoprostenol in pulmonary arterial hypertension.
Jacobs W; Vonk-Noordegraaf A
Expert Opin Drug Metab Toxicol; 2009 Jan; 5(1):83-90. PubMed ID: 19236231
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Edema After Initiation of Parenteral Prostaglandin Therapy: More Common Than We Think but How Clinically Important Is It?
Robbins IM
Chest; 2019 Jul; 156(1):7-8. PubMed ID: 31279377
[No Abstract] [Full Text] [Related]
10. Epoprostenol use for pulmonary arterial hypertension in the palliative care setting.
Wozencraft CP; Coyne PJ; Grinnan DC; Morel TD; Muzevich KM; Smith TJ
J Palliat Med; 2012 May; 15(5):619-22. PubMed ID: 22394366
[TBL] [Abstract][Full Text] [Related]
11. Safe and effective use of prostacyclins to treat pulmonary arterial hypertension.
Coons JC; Clarke M; Wanek MR; Bauer A; Bream-Rouwenhorst HR
Am J Health Syst Pharm; 2013 Oct; 70(19):1716-23. PubMed ID: 24048608
[No Abstract] [Full Text] [Related]
12. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
Aman J; Hovingh GK
Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
[No Abstract] [Full Text] [Related]
13. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
Austin ED; Hamid R
Am J Respir Crit Care Med; 2020 Jun; 201(11):1329-1331. PubMed ID: 32053755
[No Abstract] [Full Text] [Related]
14. Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: data from the French pulmonary hypertension registry.
Bergot E; Sitbon O; Cottin V; Prévot G; Canuet M; Bourdin A; de Groote P; Rottat L; Gressin V; Jaïs X; Humbert M; Simonneau G
Int J Cardiol; 2014 Apr; 172(3):561-7. PubMed ID: 24529947
[TBL] [Abstract][Full Text] [Related]
15. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
[No Abstract] [Full Text] [Related]
16. Real-World Data for Pulmonary Arterial Hypertension.
Elliott CG
Chest; 2019 Apr; 155(4):653-654. PubMed ID: 30955564
[No Abstract] [Full Text] [Related]
17. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
[No Abstract] [Full Text] [Related]
18. [Diagnosis of idiopathic pulmonary arterial hypertension by "3P" algorithm].
Fan FL; Zhang SL; Song Q; Xie XG; Zhang YP; Huo XW; Zou YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):621-625. PubMed ID: 32842275
[TBL] [Abstract][Full Text] [Related]
19. Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.
Durrani J; Toor A
Chest; 2019 Jul; 156(1):187. PubMed ID: 31279369
[No Abstract] [Full Text] [Related]
20. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
Grinnan D; Farkas L
Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
